(Q78022192)
Statements
A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis (English)
Shulman DG
Lothringer LL
Rubin JM
Briggs RB
Howes J
Novack GD
1 February 1999